Invention Grant
- Patent Title: Tissue factor pathway inhibitor antibodies and uses thereof
-
Application No.: US18182619Application Date: 2023-03-13
-
Publication No.: US12168698B2Publication Date: 2024-12-17
- Inventor: Debra Pittman , James R. Apgar , Zong Sean Juo , Macy Jin , Mark Stahl , Gregory J. Carven , Matthew Holsti , Susan Benard , Sunita R. Hett , Reema Jasuja
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Main IPC: C07K16/38
- IPC: C07K16/38 ; A61K38/48 ; A61K39/00 ; A61K39/395
Abstract:
The invention relates to antibodies, and antigen-binding fragments thereof, that specifically bind TFPI and inhibit an activity thereof. Such antibodies and fragments are useful for treating bleeding disorders and shortening clotting time.
Public/Granted literature
- US20230416405A1 TISSUE FACTOR PATHWAY INHIBITOR ANTIBODIES AND USES THEREOF Public/Granted day:2023-12-28
Information query
